-
Forward Look
Lung Cancer Screening for Smokers Almost Ready for Prime TimeStudies suggest low-dose CT screening can reduce lung cancer deaths in those at high risk.
by Sue Rochman
-
Forward Look
Coming Up ShortA limited supply of cancer medications is affecting care.
by Steve McIver
-
Forward Look
Striking a NerveDoctors are trying to find new ways to treat the painful tingling and numbness caused by cancer treatments.
by Cameron Walker
-
A Clear VisionAsking the right questions can help patients living with metastatic cancer understand the risks and benefits of recommended treatments and formulate their goals more effectively.
by Charlotte Huff
-
More Than a SignatureThe informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
-
Q&A
Support in Any LanguagePatient advocate Ivis Febus-Sampayo promotes support services for cancer patients in minority communities.
by Marci A. Landsmann
-
Forward Look
Fueling the Pediatric Cancer PipelineNew efforts are needed to push the pace of drug development.
by Leah Lawrence
-
Forward Look
It Takes a VillageImproving pediatric cancer care in developing countries
by Leah Lawrence
-
Forward Look
Identifying the Unexpected Risks of Targeted TherapyDrugs designed to single out cancer cells also may have side effects.
by Melissa Weber
-
Forward Look
Get Smart About Smartphone Cancer AppsStudy shows reasons to be skeptical about medical apps.
by Stephen Ornes
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
